Noonan syndrome: clinical features, diagnosis, and management guidelines
AA Romano, JE Allanson, J Dahlgren, BD Gelb… - …, 2010 - publications.aap.org
FINANCIAL DISCLOSURE: Dr Romano is a consultant to both Genentech, Inc and Novo
Nordisk, Inc and also participates on the speaker's bureaus of both companies; Dr Dahlgren
received grants in 2008 from Novo Nordisk, Inc for genetic analysis of individuals with NS;
Dr Gelb currently has SOS1, RAF1, and SHOC2 gene patents pending and receives
royalties for PTPN11 mutation testing from GeneDx, Correlegan, Prevention Genetics,
Baylor College of Medicine, and Harvard Partners; and Dr Roberts currently has an SOS1 …
Nordisk, Inc and also participates on the speaker's bureaus of both companies; Dr Dahlgren
received grants in 2008 from Novo Nordisk, Inc for genetic analysis of individuals with NS;
Dr Gelb currently has SOS1, RAF1, and SHOC2 gene patents pending and receives
royalties for PTPN11 mutation testing from GeneDx, Correlegan, Prevention Genetics,
Baylor College of Medicine, and Harvard Partners; and Dr Roberts currently has an SOS1 …